WelcomeUser Guide
ToSPrivacyCanary
DonateBugsLicense

©2026 Poal.co

621

"A new study published in the New England Journal of Medicine (NEJM)* has demonstrated that people who are triple-vaccinated (boosted) against COVID recover significantly more slowly from COVID infection and remain contagious for longer than people who are not vaccinated at all." 31% boosted people still contagious 10 days post-infection vs. 6% unvaccinated. Safe and effective!

"A new study published in the New England Journal of Medicine (NEJM)* has demonstrated that people who are triple-vaccinated (boosted) against COVID recover significantly more slowly from COVID infection and remain contagious for longer than people who are not vaccinated at all." 31% boosted people still contagious 10 days post-infection vs. 6% unvaccinated. Safe and effective!

(post is archived)

[–] 1 pt

I love the link to “next article” at the bottom. We’re way past clown world at this point.

CDC recommends Novavax’s COVID-19 vaccine

The Centers for Disease Control and Prevention on Tuesday recommended Novavax’s two-dose COVID-19 vaccine, NBC News reported.

The Food and Drug Administration authorized the Novavax vaccine for emergency use last week, but the CDC had to sign off before doses could be distributed to the public. An independent advisory panel to the CDC voted unanimously to recommend the vaccine on Tuesday, then CDC Director Dr. Rochelle Walensky endorsed the panel’s recommendation shortly after.

Novavax's shot, which is already available in over 40 countries, is a more traditional type of vaccine employing technology that has been used for decades to combat diseases like influenza.

"If you have been waiting for a COVID-19 vaccine built on a different technology than those previously available, now is the time to join the millions of Americans who have been vaccinated," Walensky said in a statement on Tuesday. "With COVID-19 cases on the rise again across parts of the country, vaccination is critical to help protect against the complications of severe COVID-19 disease."